Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions
Authors' conclusion
The INTERASPIRE study shows that screening for glucose perturbations in coronary patients is inadequate, achievement of lifestyle recommendations suboptimal and pharmacological management insufficient resulting in a poor risk factor control. Patients with coronary disease, especially those with glucose perturbations require professional support to achieve healthier lifestyles, and prescription of all cardioprotective medications to achieve guideline targets.
Study context
- Population
- Coronary artery disease (CAD) patients aged 18–80 years, interviewed 6 months-2 years after hospital admission; those without diabetes eligible for OGTT
- Participants
- 4,548 patients
- Outcome
- Dysglycaemia detection
Methodological detailsinternational survey, 14 countries across 6 WHO regions
- International survey
- 14 countries across 6 WHO regions
Main finding
As reported in the abstract
Known T2D
1990
44%
Previously unknown dysglycaemia on OGTT
808
40%
Previously unknown T2D on OGTT
12%
Impaired glucose tolerance (IGT) on OGTT
28%
Observational data: associations, not effects.
Further findings
Management and risk factor control in dysglycaemic patients
- Obese
- Two thirds
- Low physical activity
- A similar proportion
- Received dietary advice
- only one third
- Prescribed all guideline-recommended cardioprotective drugs
- Only half
- Attended a diabetes education program
- 16%
- A majority did not reach recommended blood pressure, lipids or HbA1c targets
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →